A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a ...
Tag: Drug
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
About 1 in 3 Americans have lost someone to a drug overdose, new study finds
Front lines of America's fentanyl crisis On the front lines of America's fentanyl crisis 04:24 About one in three Americans ...
This new weight loss drug ETF bets big on two of the industry’s leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments' GLP-1 & Weight ...
Hims & Hers says it’s selling a GLP-1 weight loss drug for 85% less than Wegovy. Here’s the price.
Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of ...
More employees are cheating on workplace drug tests. Here’s how they do it.
Cannabis industry expects reclassification of marijuana by Justice Dept. to help business Cannabis industry expects reclassification of marijuana by Justice ...
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021.Dado Ruvic ...
Diabetes drug similar to Ozempic helped slow progression of Parkinson’s disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson's diseaseSherbrooke Connectivity Imaging Lab | Getty ImagesA ...
ALS drug will be pulled from US market after study showed patients didn’t benefit
The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the ...
